EUVIMEDSkopri EUVIMED
Crossref

Insight Into the Cellular Activities of Tranexamic Acid as an Option for Melasma Treatment

Yekatsiaryna Hushcha, Anna Lisa Giuliani iD, Martini Fernanda iD, Ilaria Bononi iD, Chiara Mazziotta iD, John Charles Rotondo iD, Monica De Mattei iD

Cell Biology International · 2026

DOI: 10.1002/cbin.70097 ↗

At a glance

Journal article in Cell Biology International, 2026. Written by Yekatsiaryna Hushcha and 6 co-authors. Institution: Morgan S.r.l., R&D, Monteviale (VI), Italy. Major MEDLINE topics: Tranexamic Acid, Melanosis. Cited 4 times so far (Crossref); 80 references. Funded by: This study was supported by the University of Ferrara FAR (2020) and PRIN 2017; Morgan Srl, Monteviale (VI), Italy; Associazione Italiana per la Ricerca sul Ca….

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Melasma and other hyperpigmentation disorders represent a significant challenge in dermatology. Tranexamic acid (TXA), traditionally known for its antifibrinolytic activity via inhibition of plasminogen activation, has recently emerged as a promising depigmenting agent. However, its cellular effects on skin cells involved in melanogenesis remain poorly understood. In this study, we investigated TXA's impact on melanocytes, keratinocytes, and inflammatory cells. TXA directly inhibited melanin synthesis in B16 melanoma cells, with an additive effect when combined with α‐arbutin. In keratinocytes and macrophages, TXA attenuated inflammatory responses triggered by the plasminogen/plasmin (Plg/Plm) pathway. Moreover, TXA reduced lipopolysaccharide‐induced pro‐inflammatory gene expression in mouse macrophages, suggesting interference with Toll‐like receptor‐mediated inflammation. These findings highlight TXA's multifaceted actions on skin cells involved in pigmentation and support its therapeutic potential in melasma and potentially other skin diseases.

Subjects

MeSH terms (MEDLINE)

Tranexamic AcidMelanosisAnimalsMiceKeratinocytesMelanocytesMelaninsHumansMacrophagesAntifibrinolytic AgentsMice, Inbred C57BLPlasminogen

Author keywords

melaninmelanocytesmelasmaplasminogen (Plg)/plasmin (Plm) pathwayskin diseasestranexamic acid (TXA)

Substances

Tranexamic AcidMelaninsAntifibrinolytic AgentsPlasminogen

Authors and institutions

  • Morgan S.r.l., R&D, Monteviale (VI), Italy.
  • Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Department of Medical Sciences, Center for Studies on Gender Medicine, University of Ferrara, Ferrara, Italy.
  • Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy.
  • Centralized Laboratory of Pre-Clinical Research, University of Ferrara, Ferrara, Italy.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

ORCID profiles: Anna Lisa Giuliani, Martini Fernanda, Ilaria Bononi, Chiara Mazziotta, John Charles Rotondo, Monica De Mattei

Funding

  • This study was supported by the University of Ferrara FAR (2020) and PRIN 2017; Morgan Srl, Monteviale (VI), Italy; Associazione Italiana per la Ricerca sul Ca…

Cite

APA

Hushcha, Y., Giuliani, A. L., Fernanda, M., Bononi, I., Mazziotta, C., Rotondo, J. C., & De Mattei, M. (2026). Insight Into the Cellular Activities of Tranexamic Acid as an Option for Melasma Treatment. Cell Biology International. https://doi.org/10.1002/cbin.70097

Vancouver

Hushcha Y, Giuliani AL, Fernanda M, Bononi I, Mazziotta C, Rotondo JC, et al. Insight Into the Cellular Activities of Tranexamic Acid as an Option for Melasma Treatment. Cell Biology International. 2026. doi:10.1002/cbin.70097

BibTeX
@article{Hushcha2026,
  author = {Hushcha, Yekatsiaryna and Giuliani, Anna Lisa and Fernanda, Martini and Bononi, Ilaria and Mazziotta, Chiara and Rotondo, John Charles and De Mattei, Monica},
  title = {Insight Into the Cellular Activities of Tranexamic Acid as an Option for Melasma Treatment},
  journal = {Cell Biology International},
  year = {2026},
  doi = {10.1002/cbin.70097}
}
Start for free →